Autolus Therapeutics PLC (NAS:AUTL)
$ 3.92 0.05 (1.29%) Market Cap: 1.04 Bil Enterprise Value: 335.67 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 55/100

Autolus Therapeutics PLC Capital Markets Day Transcript

Apr 27, 2023 / 02:00PM GMT
Release Date Price: $1.73 (+5.49%)
Alexandra Deschner

Good afternoon, Good morning, and welcome to Autolus' Capital Markets Day. Thank you for joining us today. I'm Alexandra Deschner, Investor Relations Consultant for Autolus. I'm joined today by Dr. Christian Itin, Chief Executive Officer, together with members of the management team and esteemed key opinion leaders. We will be taking questions during today's webcast. If you would like to ask a question, you can do so in writing via the webcast page using the Ask a Question button. Before we begin, I would like to remind you that during today's webcast, we will make statements related to our business that are forward-looking under federal securities laws and the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

These may include, but are not limited to, statements regarding the status of clinical trials and development time lines for our product candidates and our expectations regarding our cash runway. These statements are subject to a variety of risks and uncertainties that could cause actual results to differ materially from expectations and reflect our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot